KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $16.79 $21.89 Friday, 26th Apr 2024 KURA stock ended at $19.65. This is 3.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.01% from a day low at $18.95 to a day high of $19.71.
90 days $16.79 $24.16
52 weeks $7.41 $24.16

Historical Kura Oncology prices

Date Open High Low Close Volume
Jul 12, 2023 $10.02 $10.58 $9.89 $10.30 1 945 717
Jul 11, 2023 $9.95 $10.04 $9.76 $9.90 590 436
Jul 10, 2023 $10.02 $10.11 $9.83 $9.92 1 007 014
Jul 07, 2023 $10.14 $10.20 $9.95 $10.00 920 814
Jul 06, 2023 $10.40 $10.40 $10.10 $10.12 860 490
Jul 05, 2023 $10.60 $10.79 $10.45 $10.50 570 485
Jul 03, 2023 $10.55 $10.69 $10.41 $10.60 320 106
Jun 30, 2023 $10.34 $10.64 $10.19 $10.58 840 612
Jun 29, 2023 $10.25 $10.39 $10.07 $10.28 749 135
Jun 28, 2023 $10.30 $10.35 $10.04 $10.30 1 707 179
Jun 27, 2023 $10.35 $10.39 $10.06 $10.33 1 303 119
Jun 26, 2023 $10.91 $10.91 $10.29 $10.31 1 579 049
Jun 23, 2023 $10.75 $10.97 $10.69 $10.91 1 721 357
Jun 22, 2023 $11.03 $11.09 $10.78 $10.86 811 413
Jun 21, 2023 $10.95 $11.01 $10.58 $10.72 712 171
Jun 20, 2023 $10.91 $11.17 $10.66 $11.00 1 264 402
Jun 16, 2023 $11.11 $11.11 $10.59 $10.76 2 624 955
Jun 15, 2023 $11.34 $11.50 $10.93 $10.96 2 041 460
Jun 14, 2023 $12.08 $12.69 $11.39 $11.47 4 612 370
Jun 13, 2023 $12.88 $13.07 $12.44 $12.72 1 025 142
Jun 12, 2023 $13.42 $13.70 $12.85 $12.88 1 283 338
Jun 09, 2023 $13.70 $13.70 $13.03 $13.07 509 413
Jun 08, 2023 $13.84 $14.04 $13.62 $13.70 670 939
Jun 07, 2023 $13.57 $14.04 $13.03 $13.92 880 781
Jun 06, 2023 $13.26 $13.77 $13.26 $13.51 774 705
Click to get the best stock tips daily for free!

About Kura Oncology

Kura Oncology Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi... KURA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT